Commentary on Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ, Department of Urology and Biochemistry, Mayo Clinical College of Medicine, Rochester, MN
Research output: Contribution to journal › Short survey › peer-review